dinucleotide-binding site in mice. A mutation (TGG to TGA) in C57BL/6, which would result in deletion of the signal peptide and of flavin adenine dinucleotide-binding domain, was previously discussed. 3 Such a mutation may exit, and may significantly affect renalase function in C57BL/6 mice. However, as the renalase KO mice is on a mixed genetic background, the C57BL/6 background would, if anything, reduce the severity of the observed phenotype.
Angiotensin II-induced phosphorylation of the sodium chloride cotransporter To the Editor: We read with interest the article by van der Lubbe et al., 1 which investigated the effect of angiotensin II (Ang II) on the regulation of sodium chloride transporter (NCC) in the distal convoluted tubules. From the experimental results using adrenalectomized animals, the authors concluded that Ang II increased the total and phosphorylated NCC independently of aldosterone. Although the results indicated that Ang II affected NCC independently of circulating aldosterone, there still remains a possibility that Ang II could have affected NCC by the local aldosterone synthesized in the kidney. 2 Although controversial, aldosterone could be synthesized by extra-adrenal tissues including the kidney. 2 Therefore, the Ang II-induced effect on NCC in the adrenalectomized animals could have been mediated by the local aldosterone synthesized in the kidney. Local renal aldosterone, which was increased by administration of Ang II, could have activated kinases and then increased the phosphorylation and plasma membrane abundance of NCC. Experiments with either an aldosterone synthase inhibitor or a mineralocorticoid receptor antagonist could clarify whether the effect of Ang II administration on NCC is mediated by local renal aldosterone. 3, 4 Masayuki Tanemoto 1 and Shunya Uchida 1 
